SUSRF (Surgical Science Sweden AB) Beginning Cash Position: $66.2 Mil (As of Mar. 2026)


SUSRF Surgical Science Sweden AB SUSRF
82 GF Score
Price $4.00
GF Value $14.24
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Surgical Science Sweden AB Beginning Cash Position?

Surgical Science Sweden AB SUSRF -2.20% 82 Beginning Cash Position is $66.2 Mil as of Mar. 2026. GuruFocus rates SUSRF with a GF Score™ of 82/100 and a GF Value™ of $14.24 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Surgical Science Sweden AB's Beginning Cash Position for the quarter that ended in Mar. 2026 was $66.2 Mil.

Surgical Science Sweden AB's quarterly Beginning Cash Position declined from Sep. 2025 ($65.1 Mil) to Dec. 2025 ($64.3 Mil) but then increased from Dec. 2025 ($64.3 Mil) to Mar. 2026 ($66.2 Mil).

Surgical Science Sweden AB's annual Beginning Cash Position increased from Dec. 2023 ($42.3 Mil) to Dec. 2024 ($57.7 Mil) and increased from Dec. 2024 ($57.7 Mil) to Dec. 2025 ($104.2 Mil).

Surgical Science Sweden AB Beginning Cash Position Related Terms

Surgical Science Sweden AB Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Surgical Science Sweden AB's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Surgical Science Sweden AB Beginning Cash Position Chart

Surgical Science Sweden AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.59 30.52 42.28 57.75 104.18

Surgical Science Sweden AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 95.55 64.19 65.11 64.28 66.16
SUSRF
82GF Score
Surgical Science Sweden AB SUSRF
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Surgical Science Sweden AB Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $66.2 Mil mean?
Surgical Science Sweden AB (SUSRF) has a Beginning Cash Position of $66.2 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Surgical Science Sweden AB and its competitors.
Is Surgical Science Sweden AB's Beginning Cash Position too high?
Surgical Science Sweden AB's current Beginning Cash Position is $66.2 Mil. Overall, Surgical Science Sweden AB has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Surgical Science Sweden AB's Beginning Cash Position compare to VEEV and BTSG?
Surgical Science Sweden AB's Beginning Cash Position of $66.2 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Healthcare Providers & Services company?
A good Beginning Cash Position depends on the Healthcare Providers & Services industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Surgical Science Sweden AB and its competitors. Surgical Science Sweden AB's current Beginning Cash Position is $66.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Science Sweden AB stock overvalued right now?
Based on GuruFocus' analysis, Surgical Science Sweden AB (SUSRF) is currently considered Significantly Undervalued. The stock's GF Value™ is $14.24, compared to a current price of $4.00 — trading 71.9% below its estimated fair value. The current Beginning Cash Position is $66.2 Mil. Surgical Science Sweden AB's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Surgical Science Sweden AB (SUSRF), the current Beginning Cash Position is $66.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Surgical Science Sweden AB (SUSRF) Overvalued in 2026?

Based on GuruFocus' analysis, Surgical Science Sweden AB stock appears to be undervalued. The current stock price of $4.00 is trading 71.9% below its estimated GF Value™ of $14.24. GuruFocus considers Surgical Science Sweden AB to be Significantly Undervalued.

Key valuation signals for SUSRF:

  • Beginning Cash Position: $66.2 Mil
  • GF Value™: $14.24 vs. price of $4.00 (71.9% below fair value)
  • GF Score™: 82/100 with 4 warning signs

No single metric tells the full story. See the SUSRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Surgical Science Sweden AB Business Description

Other Exchanges SUS:Sweden4P41:Germany
Address Drakegatan 7A, Gothenburg, SWE, SE-412 50
Surgical Science Sweden AB is a supplier of virtual reality simulators for medical training. The company's core is its proprietary software and hardware for simulating interactions between instruments and anatomy. It has two operating segments: Educational products include Proprietary brand medical simulator hardware and software for generic training of psycho-motor skills, instrument handling, and training for a large number of procedures and examinations prior to entering the clinical environment, as well as support and services. Industry/OEM includes simulation software for product-specific training of surgeons in robot-assisted surgery and other digitalized medical instruments, and also simulators for medical device companies.
82GF Score

Get the complete analysis for SUSRF

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.00
Price
$14.24
GF Value